Cidara Therapeutics Statistics
Total Valuation
CDTX has a market cap or net worth of $207.24 million. The enterprise value is $20.99 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CDTX has 10.95 million shares outstanding. The number of shares has increased by 45.26% in one year.
Current Share Class | 10.95M |
Shares Outstanding | 10.95M |
Shares Change (YoY) | +45.26% |
Shares Change (QoQ) | +48.97% |
Owned by Insiders (%) | 1.03% |
Owned by Institutions (%) | 14.21% |
Float | 4.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 94.22 |
Forward PS | n/a |
PB Ratio | 1.27 |
P/TBV Ratio | 1.27 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 16.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.25 |
Quick Ratio | 3.86 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -219.59% and return on invested capital (ROIC) is -69.72%.
Return on Equity (ROE) | -219.59% |
Return on Assets (ROA) | -40.46% |
Return on Invested Capital (ROIC) | -69.72% |
Return on Capital Employed (ROCE) | -55.20% |
Revenue Per Employee | $33,553 |
Profits Per Employee | -$4.47M |
Employee Count | 38 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.83% in the last 52 weeks. The beta is 0.88, so CDTX's price volatility has been lower than the market average.
Beta (5Y) | 0.88 |
52-Week Price Change | +2.83% |
50-Day Moving Average | 21.79 |
200-Day Moving Average | 16.47 |
Relative Strength Index (RSI) | 37.05 |
Average Volume (20 Days) | 147,915 |
Short Selling Information
The latest short interest is 289,926, so 2.65% of the outstanding shares have been sold short.
Short Interest | 289,926 |
Short Previous Month | 237,747 |
Short % of Shares Out | 2.65% |
Short % of Float | 6.35% |
Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, CDTX had revenue of $1.28 million and -$169.83 million in losses. Loss per share was -$26.75.
Revenue | 1.28M |
Gross Profit | -70.60M |
Operating Income | -91.22M |
Pretax Income | -36.02M |
Net Income | -169.83M |
EBITDA | -91.07M |
EBIT | -91.22M |
Loss Per Share | -$26.75 |
Full Income Statement Balance Sheet
The company has $189.83 million in cash and $3.58 million in debt, giving a net cash position of $186.25 million or $17.00 per share.
Cash & Cash Equivalents | 189.83M |
Total Debt | 3.58M |
Net Cash | 186.25M |
Net Cash Per Share | $17.00 |
Equity (Book Value) | 163.31M |
Book Value Per Share | 14.92 |
Working Capital | 161.18M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$176.53 million and capital expenditures -$129,000, giving a free cash flow of -$176.66 million.
Operating Cash Flow | -176.53M |
Capital Expenditures | -129,000 |
Free Cash Flow | -176.66M |
FCF Per Share | -$16.13 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -7,154.43% |
Pretax Margin | -13,356.16% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CDTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -45.26% |
Shareholder Yield | -45.26% |
Earnings Yield | -81.95% |
FCF Yield | -85.25% |
Analyst Forecast
The average price target for CDTX is $38.00, which is 100.85% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $38.00 |
Price Target Difference | 100.85% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 150.22% |
EPS Growth Forecast (5Y) | -50.02% |
Stock Forecasts Stock Splits
The last stock split was on April 24, 2024. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Apr 24, 2024 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
CDTX has an Altman Z-Score of -3.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.45 |
Piotroski F-Score | 1 |